Search concepts
|
Selected Filters
|
- 2,400 - 2,450 out of 158,936 results
Search results
-
Venous malformations associated with central pain: Report of a case
Cohen, S. P. & Abdi, S., Nov 1 2002, In: Anesthesia and analgesia. 95, 5, p. 1358-1360 3 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Venous imaging-based biomarkers in acute ischaemic stroke
Munuera, J., Blasco, G., Hernández-Pérez, M., Daunis-I-Estadella, P., Dávalos, A., Liebeskind, D. S., Wintermark, M., Demchuk, A., Menon, B. K., Thomalla, G., Nael, K., Pedraza, S. & Puig, J., Jan 1 2017, In: Journal of Neurology, Neurosurgery and Psychiatry. 88, 1, p. 62-69 8 p.Research output: Contribution to journal › Review article › peer-review
20 Scopus citations -
Venous drainage of the radial forearm flap: Comparison of the deep and superficial systems
Selber, J. C., Sanders, E., Lin, H. & Yu, P., Apr 2011, In: Annals of plastic surgery. 66, 4, p. 347-350 4 p.Research output: Contribution to journal › Article › peer-review
30 Scopus citations -
Venous chest anatomy: Clinical implications
Chasen, M. H. & Charnsangavej, C., Mar 1998, In: European Journal of Radiology. 27, 1, p. 2-14 13 p.Research output: Contribution to journal › Article › peer-review
33 Scopus citations -
Veno-occlusive disease of the liver after blood and marrow transplantation: Analysis of pre- and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator
Litzow, M. R., Repoussis, P. D., Schroeder, G., Schembri-Wismayer, D., Batts, K. P., Anderson, P. M., Arndt, C. A. S., Chen, M. G., Gastineau, D. A., Gertz, M. A., Inwards, D. J., Lacy, M. Q., Tefferi, A., Noël, P., Solberg, L. A., Letendre, L. & Hoagland, H. C., Nov 1 2002, In: Leukemia and Lymphoma. 43, 11, p. 2099-2107 9 p.Research output: Contribution to journal › Article › peer-review
22 Scopus citations -
VennMaster: area-proportional Euler diagrams for functional GO analysis of microarrays.
Kestler, H. A., Müller, A., Kraus, J. M., Buchholz, M., Gress, T. M., Liu, H., Kane, D. W., Zeeberg, B. R. & Weinstein, J. N., 2008, In: BMC bioinformatics. 9, p. 67 1 p., 67.Research output: Contribution to journal › Article › peer-review
91 Scopus citations -
Veni, Vidi, Vici: In Vivo Molecular Imaging of Immune Response
Gross, S., Moss, B. L. & Piwnica-Worms, D., Oct 26 2007, In: Immunity. 27, 4, p. 533-538 6 p.Research output: Contribution to journal › Comment/debate › peer-review
15 Scopus citations -
Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 study
Rutherford, S. C., Abramson, J. S., Bartlett, N. L., Barta, S. K., Khan, N., Joyce, R., Maddocks, K., Ali-Shaw, T., Senese, S., Yuan, Y., Westin, J. & Leonard, J. P., Nov 2021, In: The Lancet Haematology. 8, 11, p. e818-e827Research output: Contribution to journal › Article › peer-review
15 Scopus citations -
Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortality
Maiti, A., Qiao, W., Sasaki, K., Ravandi, F., Kadia, T. M., Jabbour, E. J., Daver, N. G., Borthakur, G., Garcia-Manero, G., Pierce, S. A., Montalbano, K. S., Pemmaraju, N., Naqvi, K., Ohanian, M., Short, N. J., Alvarado, Y., Takahashi, K., Yilmaz, M., Jain, N., Kornblau, S. M., & 11 others , Mar 1 2021, In: American journal of hematology. 96, 3, p. 282-291 10 p.Research output: Contribution to journal › Article › peer-review
Open Access60 Scopus citations -
Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow-up from a phase 1b study
Pollyea, D. A., Pratz, K., Letai, A., Jonas, B. A., Wei, A. H., Pullarkat, V., Konopleva, M., Thirman, M. J., Arellano, M., Becker, P. S., Chyla, B., Hong, W. J., Jiang, Q., Potluri, J. & DiNardo, C. D., Feb 1 2021, In: American journal of hematology. 96, 2, p. 208-217 10 p.Research output: Contribution to journal › Article › peer-review
Open Access86 Scopus citations -
Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon
Lew, T. E., Bennett, R., Lin, V. S., Whitechurch, A., Handunnetti, S. M., Marlton, P., Shen, Y., Mulligan, S. P., Casan, J., Blombery, P., Tam, C. S., Roberts, A. W., Seymour, J. F., Thompson, P. A. & Anderson, M. A., Mar 26 2024, In: Blood Advances. 8, 6, p. 1439-1443 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access2 Scopus citations -
Venetoclax resistance: Mechanistic insights and future strategies
Ong, F., Kim, K. & Konopleva, M. Y., 2022, In: Cancer Drug Resistance. 5, 2, p. 380-400 21 p.Research output: Contribution to journal › Review article › peer-review
Open Access31 Scopus citations -
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial
Wei, A. H., Montesinos, P., Ivanov, V., DiNardo, C. D., Novak, J., Laribi, K., Kim, I., Stevens, D. A., Fiedler, W., Pagoni, M., Samoilova, O., Hu, Y., Anagnostopoulos, A., Bergeron, J., Hou, J. Z., Murthy, V., Yamauchi, T., McDonald, A., Chyla, B., Gopalakrishnan, S., & 4 others , Jun 2020, In: Blood. 135, 24, p. 2137-2145 9 p.Research output: Contribution to journal › Article › peer-review
Open Access449 Scopus citations -
Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial
Kadia, T. M., Reville, P. K., Borthakur, G., Yilmaz, M., Kornblau, S., Alvarado, Y., Dinardo, C. D., Daver, N., Jain, N., Pemmaraju, N., Short, N., Wang, S. A., Tidwell, R. S. S., Islam, R., Konopleva, M., Garcia-Manero, G., Ravandi, F. & Kantarjian, H. M., Aug 2021, In: The Lancet Haematology. 8, 8, p. e552-e561Research output: Contribution to journal › Article › peer-review
Open Access84 Scopus citations -
Venetoclax Plus Gilteritinib for FLT3 -Mutated Relapsed/Refractory Acute Myeloid Leukemia
Daver, N., Perl, A. E., Maly, J., Levis, M., Ritchie, E., Litzow, M., McCloskey, J., Smith, C. C., Schiller, G., Bradley, T., Tiu, R. V., Naqvi, K., Dail, M., Brackman, D., Siddani, S., Wang, J., Chyla, B., Lee, P. & Altman, J. K., Dec 10 2022, In: Journal of Clinical Oncology. 40, 35, p. 4048-4059 12 p.Research output: Contribution to journal › Article › peer-review
Open Access76 Scopus citations -
Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome
Davids, M. S., Rogers, K. A., Tyekucheva, S., Wang, Z., Pazienza, S., Renner, S. K., Montegaard, J., Ihuoma, U., Lehmberg, T. Z., Parry, E. M., Wu, C. J., Jacobson, C. A., Fisher, D. C., Thompson, P. A. & Brown, J. R., Feb 3 2022, In: Blood. 139, 5, p. 686-689 4 p.Research output: Contribution to journal › Article › peer-review
Open Access31 Scopus citations -
Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
Yamamoto, K., Shinagawa, A., Dinardo, C. D., Pratz, K. W., Ishizawa, K., Miyamoto, T., Komatsu, N., Nakashima, Y., Yoshida, C., Fukuhara, N., Usuki, K., Yamauchi, T., Asada, N., Asou, N., Choi, I., Miyazaki, Y., Honda, H., Okubo, S., Kurokawa, M., Zhou, Y., & 3 others , Jan 1 2022, In: Japanese journal of clinical oncology. 52, 1, p. 29-38 10 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
Venetoclax is safe and efficacious in relapsed/refractory AML
Ganzel, C., Ram, R., Gural, A., Wolach, O., Gino-Moor, S., Vainstein, V., Nachmias, B., Apel, A., Koren-Michowitz, M., Pasvolsky, O., Yerushalmi, R., Danylesko, I., Cohen, Y., Peretz, G., Moshe, Y., Zektser, M., Yeganeh, S., Rowe, J. M. & Ofran, Y., Jul 28 2020, In: Leukemia and Lymphoma. 61, 9, p. 2221-2225 5 p.Research output: Contribution to journal › Article › peer-review
33 Scopus citations -
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
Stilgenbauer, S., Eichhorst, B., Schetelig, J., Coutre, S., Seymour, J. F., Munir, T., Puvvada, S. D., Wendtner, C. M., Roberts, A. W., Jurczak, W., Mulligan, S. P., Böttcher, S., Mobasher, M., Zhu, M., Desai, M., Chyla, B., Verdugo, M., Enschede, S. H., Cerri, E., Humerickhouse, R., & 3 others , Jun 1 2016, In: The lancet oncology. 17, 6, p. 768-778 11 p.Research output: Contribution to journal › Article › peer-review
667 Scopus citations -
Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease
Sanber, K., Ye, K., Tsai, H. L., Newman, M., Webster, J. A., Gojo, I., Ghiaur, G., Prince, G. T., Gondek, L. P., Smith, B. D., Levis, M. J., DeZern, A. E., Ambinder, A. J., Dalton, W. B. & Jain, T., 2023, In: Leukemia and Lymphoma. 64, 4, p. 846-855 10 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Venetoclax in acute myeloid leukemia–current and future directions
Lachowiez, C., DiNardo, C. D. & Konopleva, M., May 11 2020, In: Leukemia and Lymphoma. 61, 6, p. 1313-1322 10 p.Research output: Contribution to journal › Article › peer-review
35 Scopus citations -
Venetoclax for patients with chronic lymphocytic leukemia with 17p deletion: Results from the full population of a phase ii pivotal trial
Stilgenbauer, S., Eichhorst, B., Schetelig, J., Hillmen, P., Seymour, J. F., Coutre, S., Jurczak, W., Mulligan, S. P., Schuh, A., Assouline, S., Wendtner, C. M., Roberts, A. W., Davids, M. S., Bloehdorn, J., Munir, T., Böttcher, S., Zhou, L., Salem, A. H., Desai, M., Chyla, B., & 6 others , Jul 1 2018, In: Journal of Clinical Oncology. 36, 19, p. 1973-1980 8 p.Research output: Contribution to journal › Article › peer-review
249 Scopus citations -
Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy
Coutre, S., Choi, M., Furman, R. R., Eradat, H., Heffner, L., Jones, J. A., Chyla, B., Zhou, L., Agarwal, S., Waskiewicz, T., Verdugo, M., Humerickhouse, R. A., Potluri, J., Wierda, W. G. & Davids, M. S., Apr 12 2018, In: Blood. 131, 15, p. 1704-1711 8 p.Research output: Contribution to journal › Article › peer-review
Open Access114 Scopus citations -
Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial
Jones, J. A., Mato, A. R., Wierda, W. G., Davids, M. S., Choi, M., Cheson, B. D., Furman, R. R., Lamanna, N., Barr, P. M., Zhou, L., Chyla, B., Salem, A. H., Verdugo, M., Humerickhouse, R. A., Potluri, J., Coutre, S., Woyach, J. & Byrd, J. C., Jan 2018, In: The lancet oncology. 19, 1, p. 65-75 11 p.Research output: Contribution to journal › Article › peer-review
315 Scopus citations -
Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B-cell receptor pathway inhibitor
Wierda, W. G., Byrd, J. C., Davids, M. S., Furman, R. R., Cheson, B. D., Barr, P. M., Eradat, H., Heffner, L., Zhou, L., Verdugo, M., Potluri, J. & Choi, M., Jun 2019, In: British Journal of Haematology. 185, 5, p. 961-966 6 p.Research output: Contribution to journal › Letter › peer-review
Open Access12 Scopus citations -
Venetoclax for children and adolescents with acute lymphoblastic leukemia and lymphoblastic lymphoma
Gibson, A., Trabal, A., McCall, D., Khazal, S., Toepfer, L., Bell, D. H., Roth, M., Mahadeo, K. M., Nunez, C., Short, N. J., Dinardo, C., Konopleva, M., Issa, G. C., Ravandi, F., Jain, N., Borthakur, G., Kantarjian, H. M., Jabbour, E. & Cuglievan, B., Jan 1 2022, In: Cancers. 14, 1, 150.Research output: Contribution to journal › Article › peer-review
Open Access30 Scopus citations -
Venetoclax for AML: Changing the treatment paradigm
Pollyea, D. A., Amaya, M., Strati, P. & Konopleva, M. Y., Dec 23 2019, In: Blood Advances. 3, 24, p. 4326-4335 10 p.Research output: Contribution to journal › Article › peer-review
Open Access113 Scopus citations -
Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience
Trabal, A., Gibson, A., He, J., McCall, D., Roth, M., Nuñez, C., Garcia, M., Buzbee, M., Toepfer, L., Bidikian, A., Daver, N., Kadia, T., Short, N. J., Issa, G. C., Ravandi, F., DiNardo, C. D., Montalban Bravo, G., Garces, S., Marcogliese, A., Paek, H., & 8 others , Apr 2023, In: Cancers. 15, 7, 1983.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
Venetoclax enhances T cell–mediated antileukemic activity by increasing ROS production
Lee, J. B., Khan, D. H., Hurren, R., Xu, M., Na, Y., Kang, H., Mirali, S., Wang, X., Gronda, M., Jitkova, Y., MacLean, N., Arruda, A., Alaniz, Z., Konopleva, M. Y., Andreeff, M., Minden, M. D., Zhang, L. & Schimmer, A. D., Jul 22 2021, In: Blood. 138, 3, p. 234-245 12 p.Research output: Contribution to journal › Article › peer-review
Open Access77 Scopus citations -
Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRD
Thompson, P. A., Keating, M. J., Ferrajoli, A., Jain, N., Peterson, C. B., Garg, N., Wang, S. A., Jorgensen, J. L., Kadia, T. M., Bose, P., Pemmaraju, N., Short, N. J. & Wierda, W. G., Jul 2023, In: Leukemia. 37, 7, p. 1444-1453 10 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia models
Mali, R. S., Zhang, Q., DeFilippis, R. A., Cavazos, A., Kuruvilla, V. M., Raman, J., Mody, V., Choo, E. F., Dail, M., Shah, N. P., Konopleva, M., Sampath, D. & Lasater, E. A., Apr 2021, In: Haematologica. 106, 4, p. 1034-1046 13 p.Research output: Contribution to journal › Article › peer-review
Open Access71 Scopus citations -
Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort study
Lachowiez, C. A., Reville, P. K., Kantarjian, H., Jabbour, E., Borthakur, G., Daver, N., Loghavi, S., Furudate, K., Xiao, L., Pierce, S., Short, N. J., Maiti, A., Yilmaz, M., Sasaki, K., Takahashi, K., Konopleva, M., Pemmaraju, N., Popat, U., Shpall, E., Garcia-Manero, G., & 3 others , May 2022, In: The Lancet Haematology. 9, 5, p. e350-e360Research output: Contribution to journal › Article › peer-review
Open Access30 Scopus citations -
Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia
DiNardo, C. D., Lachowiez, C. A., Takahashi, K., Loghavi, S., Xiao, L., Kadia, T., Daver, N., Adeoti, M., Short, N. J., Sasaki, K., Wang, S., Borthakur, G., Issa, G., Maiti, A., Alvarado, Y., Pemmaraju, N., Bravo, G. M., Masarova, L., Yilmaz, M., Jain, N., & 7 others , Sep 1 2021, In: Journal of Clinical Oncology. 39, 25, p. 2768-2778 11 p.Research output: Contribution to journal › Article › peer-review
Open Access168 Scopus citations -
Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia
DiNardo, C. D., Lachowiez, C. A., Takahashi, K., Loghavi, S., Kadia, T., Daver, N., Xiao, L., Adeoti, M., Short, N. J., Sasaki, K., Wang, S. A., Borthakur, G., Issa, G., Maiti, A., Alvarado, Y., Pemmaraju, N., Bravo, G. M., Masarova, L., Yilmaz, M., Jain, N., & 7 others , Aug 2022, In: American journal of hematology. 97, 8, p. 1035-1043 9 p.Research output: Contribution to journal › Article › peer-review
30 Scopus citations -
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
DiNardo, C. D., Pratz, K., Pullarkat, V., Jonas, B. A., Arellano, M., Becker, P. S., Frankfurt, O., Konopleva, M., Wei, A. H., Kantarjian, H. M., Xu, T., Hong, W. J., Chyla, B., Potluri, J., Pollyea, D. A. & Letai, A., Jan 3 2019, In: Blood. 133, 1, p. 7-17 11 p.Research output: Contribution to journal › Article › peer-review
Open Access1183 Scopus citations -
Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia
Pratz, K. W., Panayiotidis, P., Recher, C., Wei, X., Jonas, B. A., Montesinos, P., Ivanov, V., Schuh, A. C., DiNardo, C. D., Novak, J., Pejsa, V., Stevens, D., Yeh, S. P., Kim, I., Turgut, M., Fracchiolla, N., Yamamoto, K., Ofran, Y., Wei, A. H., Bui, C. N., & 6 others , Apr 2022, In: Blood cancer journal. 12, 4, 71.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations -
Venetoclax-based therapies for acute myeloid leukemia
Guerra, V. A., DiNardo, C. & Konopleva, M., Jun 2019, In: Best Practice and Research: Clinical Haematology. 32, 2, p. 145-153 9 p.Research output: Contribution to journal › Review article › peer-review
Open Access105 Scopus citations -
Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future Directions
Samra, B., Konopleva, M., Isidori, A., Daver, N. & DiNardo, C., Nov 5 2020, In: Frontiers in Oncology. 10, 562558.Research output: Contribution to journal › Review article › peer-review
Open Access40 Scopus citations -
Venetoclax and navitoclax in combination with chemotherapy in patients with relapsed or refractory acute lymphoblastic leukemia and lymphoblastic lymphoma
Pullarkat, V. A., Lacayo, N. J., Jabbour, E., Rubnitz, J. E., Bajel, A., Laetsch, T. W., Leonard, J., Colace, S. I., Khaw, S. L., Fleming, S. A., Mattison, R. J., Norris, R., Opferman, J. T., Roberts, K. G., Zhao, Y., Qu, C., Badawi, M., Schmidt, M., Tong, B., Pesko, J. C., & 9 others , 2021, In: Cancer discovery. 11, 6, p. 1440-1453 14 p.Research output: Contribution to journal › Article › peer-review
Open Access144 Scopus citations -
Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial
Daver, N. G., Dail, M., Garcia, J. S., Jonas, B. A., Yee, K. W. L., Kelly, K. R., Vey, N., Assouline, S., Roboz, G. J., Paolini, S., Pollyea, D. A., Tafuri, A., Brandwein, J. M., Pigneux, A., Powell, B. L., Fenaux, P., Olin, R. L., Visani, G., Martinelli, G., Onishi, M., & 7 others , Mar 16 2023, In: Blood. 141, 11, p. 1265-1276 12 p.Research output: Contribution to journal › Article › peer-review
Open Access32 Scopus citations -
Venetoclax and hypomethylating agents in older/unfit patients with blastic plasmacytoid dendritic cell neoplasm
Gangat, N., Konopleva, M., Patnaik, M. M., Jabbour, E., DiNardo, C., Al-Kali, A., Foran, J. M., Granroth, G. L., Olteanu, H., Kadia, T., Tefferi, A. & Pemmaraju, N., Feb 1 2022, In: American journal of hematology. 97, 2, p. E62-E67Research output: Contribution to journal › Letter › peer-review
17 Scopus citations -
Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemia
Aldoss, I., Zhang, J., Mei, M., Al Malki, M. M., Arslan, S., Ngo, D., Aribi, A., Ali, H., Sandhu, K., Salhotra, A., Koller, P., Khaled, S., Artz, A., Snyder, D., Nakamura, R., Forman, S. J., Stein, A. S., Marcucci, G. & Pullarkat, V., Oct 1 2020, In: American journal of hematology. 95, 10, p. 1193-1199 7 p.Research output: Contribution to journal › Article › peer-review
Open Access30 Scopus citations -
Venetoclax and Decitabine in Pediatric Refractory T-cell Lymphoblastic Lymphoma
Baig, M. U., Rytting, M., Roth, M., Morani, A. C., Nunez, C., Lin, P. & Cuglievan, B., Oct 1 2021, In: Journal of Pediatric Hematology/Oncology. 43, 7, p. E991-E996Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial
Konopleva, M., Dail, M., Daver, N. G., Garcia, J. S., Jonas, B. A., Yee, K. W. L., Kelly, K. R., Vey, N., Assouline, S., Roboz, G. J., Paolini, S., Pollyea, D. A., Tafuri, A., Brandwein, J. M., Pigneux, A., Powell, B. L., Fenaux, P., Olin, R. L., Visani, G., Martinelli, G., & 8 others , 2024, (Accepted/In press) In: Clinical Lymphoma, Myeloma and Leukemia.Research output: Contribution to journal › Article › peer-review
Open Access -
Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias
Maiti, A., Franquiz, M. J., Ravandi, F., Cortes, J. E., Jabbour, E. J., Sasaki, K., Marx, K., Daver, N. G., Kadia, T. M., Konopleva, M. Y., Masarova, L., Borthakur, G., DInardo, C. D., Naqvi, K., Pierce, S., Kantarjian, H. M. & Short, N. J., Dec 2020, In: Acta haematologica. 143, 6, p. 567-573 7 p.Research output: Contribution to journal › Article › peer-review
Open Access53 Scopus citations -
Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country
Senapati, J., Dhawan, R., Aggarwal, M., Kumar, P., Kumar Vishwanathan, G., Dass, J., Tyagi, S., Mahapatra, M. & Seth, T., 2021, In: Leukemia and Lymphoma. 62, 6, p. 1514-1517 4 p.Research output: Contribution to journal › Letter › peer-review
4 Scopus citations -
Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia
Senapati, J., Urrutia, S., Loghavi, S., Short, N. J., Issa, G. C., Maiti, A., Abbas, H. A., Daver, N. G., Pemmaraju, N., Pierce, S., Chien, K. S., Sasaki, K., Kadia, T. M., Hammond, D. E., Borthakur, G., Patel, K., Ravandi, F., Kantarjian, H. M., Garcia-Manero, G. & DiNardo, C. D., Nov 9 2023, In: Blood. 142, 19, p. 1647-1657 11 p.Research output: Contribution to journal › Article › peer-review
15 Scopus citations -
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: A phase Ib dose-finding study
De Vos, S., Swinnen, L. J., Wang, D., Reid, E., Fowler, N., Cordero, J., Dunbar, M., Enschede, S. H., Nolan, C., Petrich, A. M., Ross, J. A., Salem, A. H., Verdugo, M., Agarwal, S., Zhou, L., Kozloff, M., Nastoupil, L. J. & Flowers, C. R., Sep 1 2018, In: Annals of Oncology. 29, 9, p. 1932-1938 7 p.Research output: Contribution to journal › Article › peer-review
Open Access58 Scopus citations -
Venereal warts
Rapini, R. P., 1990, In: Primary Care - Clinics in Office Practice. 17, 1, p. 127-144 18 p.Research output: Contribution to journal › Review article › peer-review
4 Scopus citations -
Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600E
Hallmeyer, S., Gonzalez, R., Lawson, D. H., Cranmer, L. D., Linette, G. P., Puzanov, I., Taback, B., Cowey, C. L., Ribas, A., Daniels, G. A., Moore, T., Gibney, G. T., Tawbi, H., Whitman, E., Lee, G., Mun, Y., Liu, S. & Hamid, O., 2017, In: Melanoma research. 27, 6, p. 585-590 6 p.Research output: Contribution to journal › Article › peer-review
18 Scopus citations